Tectonic Therapeutic, Inc. TECX
Updated: 10 Aug 2026
No signal published yet
We already track Tectonic Therapeutic and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow Tectonic Therapeutic, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Tectonic Therapeutic free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
On August 6, 2026, Tectonic Therapeutic reported its second quarter 2026 financial results and clinical progress. The company completed patient enrollment in its global Phase 2 APEX trial for TX45, with topline results expected in early Q1 2027. Additionally, dosing was completed in the Phase 1a trial of TX2100, with topline data anticipated by the end of Q3 2026.
What Firelda Watch includes for Tectonic Therapeutic, Inc.
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow Tectonic Therapeutic, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Tectonic Therapeutic free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more